MALIGNANT OVARIAN ENDOMETRIOID TUMOR

Clinical trials for MALIGNANT OVARIAN ENDOMETRIOID TUMOR explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT OVARIAN ENDOMETRIOID TUMOR trials appear

Sign up with your email to follow new studies for MALIGNANT OVARIAN ENDOMETRIOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test Immune-Boosting combo to fight returning ovarian cancer

Disease control Ongoing

This study is testing if a two-drug combination works better than a single drug to control recurrent ovarian, fallopian tube, or peritoneal cancer that still responds to platinum chemotherapy. It compares a targeted pill (olaparib) alone to the pill plus an immunotherapy drug (tr…

Matched conditions: MALIGNANT OVARIAN ENDOMETRIOID TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

MALIGNANT OVARIAN ENDOMETRIOID TUMOR

Get alerted when new MALIGNANT OVARIAN ENDOMETRIOID TUMOR trials appear

Scientists test Immune-Boosting combo to fight returning ovarian cancer